Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery synthesizes new JAK3 inhibitors

Jan. 20, 2022

Sun Pharmaceutical Industries divulges GIPR and GLP-1 receptor dual agonists

Jan. 20, 2022

Jiangsu Hengrui Medicine and Shanghai Hengrui Pharmaceutical patent new ATR kinase inhibitors

Jan. 20, 2022

Kallyope presents new AMPK activators

Jan. 20, 2022

Nanodecoys scavenge RANKL and TNF-alpha for osteoporosis treatment

Jan. 20, 2022

Targeting DICAM impedes migration of disease-inducing leukocytes into the CNS in multiple sclerosis

Jan. 20, 2022

Oncostatin M blockade ameliorates severe asthma

Jan. 20, 2022

Amyloid aggregates differ in familial and sporadic AD

Jan. 19, 2022

Subcutaneous nanocarrier-mediated delivery of rapamycin

Jan. 19, 2022

NT-I7 promotes longer survival in murine models of glioma through CD8+ T cells

Jan. 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...